Development of a Novel Stress Testing Protocol to Define the Relationship Between Coronary Microvascular Dysfunction and Diastology in Women With Angina But No Evidence of Obstructive Coronary Artery Disease

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-60
SponsorCedars-Sinai Medical Center

About this trial

Microvascular coronary dysfunction (MCD) (abnormities in small blood vessels/arteries in heart) with symptoms of persistent chest pain, primarily impacts women. There are an estimated 2-3 million women in the US with MCD and about 100,000 new cases annually. Recent data from our research group suggests that coronary microvascular disease impairs the way the heart relaxes. This pilot study will attempt to exacerbate this phenotype in an effort to better understand the pathophysiology of the disease. The investigators will recruit 30 volunteers total (10 healthy calibration subjects, 10 women with microvascular disease, and 10 age-match women for the group with microvascular disease). Subjects will undergo a series of "stress" maneuvers in conjunction with advanced cardiac magnetic resonance imaging.

Eligibility criteria

Qualifiers

Fully understanding and willing to undergo study procedures

Male or Female greater than or equal to 18 years of age

Understanding and willing to sign consent form.

Disqualifiers

History of cardiovascular, pulmonary, or neurological disease

Hypertension (sitting blood pressure >140/90 mmHg, with measurements recorded on at least 2 occasions)

Diabetes

Unable to give informed consent;

Trial design

Treatments tested in this trial

  • Handgrip
  • Altitude simulation
  • Leg exercise

Treatment groups

30 Participants
are divided into 3 treatment groups

Sponsors and collaborators